Sera from lipopolysaccharide (LPS)-injected mice exhibit complement-dependent cytotoxicity against syngeneic and autologous spleen cells.
D000818:Animals; D003165:Complement System Proteins / Q000378:metabolism*; D003602:Cytotoxicity, Immunologic; D004926:Escherichia coli / Q000276:immunology; D005260:Female; D006461:Hemolysis; D007106:Immune Sera / Q000494:pharmacology*; D007136:Immunoglobulins / Q000096:biosynthesis; D007164:Immunosorbents; D007700:Kinetics; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D011817:Rabbits; D013154:Spleen / Q000276:immunology*
D007106:Immune Sera; D007136:Immunoglobulins; D007164:Immunosorbents; D008070:Lipopolysaccharides; D003165:Complement System Proteins